Product Information

OMEPRAZOLE-BICARB 40-1,100 CAP is a generic product labeled by Cipla USA Inc., priced at $0.5549 per EA under NDC 69097091402. Its NADAC has been published 510 times since Feb 8, 2017.

FDA first approved this application on Dec 6, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OMEPRAZOLE-BICARB 40-1,100 CAP

omeprazole sodium bicarbonate
$0.5549per EA

Strength

40; 1100 mg/1; mg/1

Manufacturer

Cipla USA Inc.

NDC

69097091402

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207476

FDA Approved

12/6/2016

TE Code

AB

On Market Since

1/30/2017

Pharmacological Classes

Alkalinizing Activity
Cytochrome P450 2C19 Inhibitors
Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for OMEPRAZOLE-BICARB 40-1,100 CAP has been published 510 times since Feb 8, 2017, and over the history we have for it it has declined 98.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5549 per EA
All-time high$30.7203 (Mar 15, 2017)
All-time low$0.5100 (Jan 21, 2026)
52-week high$0.6187
52-week low$0.5100
Median price$1.1408
Average price$2.8669
Largest weekly change+61.3% (Jan 17, 2024)
Weeks tracked510
Tracking sinceFeb 8, 2017

Price History

1W

0.0%

1M

-1.3%

3M

-4.1%

6M

-10.3%

1Y

-13.3%

3Y

-29.3%

5Y

-52.7%

All

-98.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the omeprazole sodium bicarbonate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OMEPRAZOLE-BICARB 40-1,100 CAP?

The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE-BICARB 40-1,100 CAP, manufactured by Cipla USA Inc., is $0.5549 per EA (NDC 69097091402), effective Nov 11, 2026.

How has the price of OMEPRAZOLE-BICARB 40-1,100 CAP changed over time?

Over the history we have for it, the NADAC for OMEPRAZOLE-BICARB 40-1,100 CAP has declined 98.1%. It has been tracked across 510 weekly CMS publications since Feb 8, 2017.

What are the highest and lowest recorded NADAC prices for OMEPRAZOLE-BICARB 40-1,100 CAP?

Since Feb 8, 2017, the NADAC for OMEPRAZOLE-BICARB 40-1,100 CAP has ranged from a low of $0.5100 (Jan 21, 2026) to a high of $30.7203 (Mar 15, 2017), with a median of $1.1408 per EA.

Are there cheaper alternatives to OMEPRAZOLE-BICARB 40-1,100 CAP?

No other NADAC-published product currently shares the active ingredient and strength of OMEPRAZOLE-BICARB 40-1,100 CAP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OMEPRAZOLE-BICARB 40-1,100 CAP?

OMEPRAZOLE-BICARB 40-1,100 CAP (NDC 69097091402) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.